Meropenem recalls
The FDA has published 2 recalls involving Meropenem since 2016. The latest was reported on 31 Oct 2018. Most were for sterility. Pfizer has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2016
Last 12 months0reported
Class I00% of total
Ongoing0latest 31 Oct 2018
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why meropenem is recalled
Companies
By year
All meropenem recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Meropenem for Injection, USA (I.V.), 25 vials per, Sterile recalled | Pfizer | Sterility | Nationwide |
| Drug | CLASS II | Meropenem in NS, Packaged as a) 1000MG in Homepumps recalled | Sentara Enterprises | Sterility | NC, VA |
Should you stop taking Meropenem?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.